Abstract:Importance: The influence of sleep-disordered breathing (SDB) and sleep-related hypoxemia in SARS-CoV-2 viral infection and COVID-19 outcomes remains unknown. Controversy exists regarding whether to continue treatment for SDB with positive airway pressure given concern for aerosolization with limited data to inform professional society recommendations. Objective: To investigate the association of SDB (identified via polysomnogram) and sleep-related hypoxia with (1) SARS-CoV-2 positivity and (2) World Health Organization (WHO)-designated COVID-19 clinical outcomes while accounting for confounding including obesity, underlying cardiopulmonary disease, cancer, and smoking history. Design, setting, and participants: This case-control study was conducted within the Cleveland Clinic Health System (Ohio and Florida) and included all patients who were tested for COVID-19 between March 8 and November 30, 2020, and who had an available sleep study record. Sleep indices and SARS-CoV-2 positivity were assessed with overlap propensity score weighting, and COVID-19 clinical outcomes were assessed using the institutional registry. Exposures: Sleep study-identified SDB (defined by frequency of apneas and hypopneas using the Apnea-Hypopnea Index [AHI]) and sleep-related hypoxemia (percentage of total sleep time at <90% oxygen saturation [TST <90]). Main outcomes and measures: Outcomes were SARS-CoV-2 infection and WHO-designated COVID-19 clinical outcomes (hospitalization, use of supplemental oxygen, noninvasive ventilation, mechanical ventilation or extracorporeal membrane oxygenation, and death). Results: Of 350 710 individuals tested for SARS-CoV-2, 5402 (mean [SD] age, 56.4 [14.5] years; 3005 women [55.6%]) had a prior sleep study, of whom 1935 (35.8%) tested positive for SARS-CoV-2. Of the 5402 participants, 1696 were Black (31.4%), 3259 were White (60.3%), and 822 were of other race or ethnicity (15.2%). Patients who were positive vs negative for SARS-CoV-2 had a higher AHI score (median, 16.2 events/h [IQR, 6.1-39.5 events/h] vs 13.6 events/h [IQR, 5.5-33.6 events/h]; P < .001) and increased TST <90 (median, 1.8% sleep time [IQR, 0.10%-12.8% sleep time] vs 1.4% sleep time [IQR, 0.10%-10.8% sleep time]; P = .02). After overlap propensity score-weighted logistic regression, no SDB measures were associated with SARS-CoV-2 positivity. Median TST <90 was associated with the WHO-designated COVID-19 ordinal clinical outcome scale (adjusted odds ratio, 1.39; 95% CI, 1.10-1.74; P = .005). Time-to-event analyses showed sleep-related hypoxia associated with a 31% higher rate of hospitalization and mortality (adjusted hazard ratio, 1.31; 95% CI, 1.08-1.57; P = .005). Conclusions and relevance: In this case-control study, SDB and sleep-related hypoxia were not associated with increased SARS-CoV-2 positivity; however, once patients were infected with SARS-CoV-2, sleep-related hypoxia was an associated risk factor for detrimental COVID-19 outcomes.

Association of Sleep Quality Before and after SARS-CoV-2 Infection with Clinical Outcomes in Hospitalized Patients with COVID-19 in China

Poor-sleep is Associated with Slow Recovery from Lymphopenia and an Increased Need for ICU Care in Hospitalized Patients with COVID-19: A Retrospective Cohort Study

Prevalence of poor sleep quality in COVID-19 patients: a systematic review and meta-analysis

Pre-hospital, In-Hospital and Post-Hospital Factors Associated with Sleep Quality among COVID-19 Survivors 6 Months after Hospital Discharge: Cross-Sectional Survey in Five Cities in China

The association between probable post‐COVID‐19 condition and sleep‐related parameters: a longitudinal study of non‐hospitalised patients

Sleep and mental health during the COVID-19 pandemic: findings from an online questionnaire survey in China

Relationships between the changes in sleep patterns and sleep quality among Chinese people during the 2019 coronavirus disease outbreak

Assessment of sleep quality in severe covid-19 hospitalized patients

Prevalence and Demographic Correlates of Poor Sleep Quality Among Frontline Health Professionals in Liaoning Province, China During the COVID-19 Outbreak

Social Support Moderates the Relationship Between Sleep Quality and Mental Health: A Chinese Fangcang Shelter Hospital-Based Study in Asymptomatic COVID-19 Carriers

Sleep disturbances among Chinese residents during the Coronavirus Disease 2019 outbreak and associated factors

Psychological distress and sleep quality of COVID-19 patients in Wuhan, a lockdown city as the epicenter of COVID-19

Association of Sleep-Related Hypoxia With Risk of COVID-19 Hospitalizations and Mortality in a Large Integrated Health System

Sleep Quality and Mental Health among Asymptomatic COVID-19 Carriers from Fangcang Shelter Hospitals：The Moderating Role of Social Support

The Impact of SARS-CoV-2 Infection on Sleep, Daytime Sleepiness, and Depression-Longitudinal Cohort Study

Relationship Between Sleep Quality and Mental Health Before and after COVID-19 Epidemic among Rural Older Adults in Shandong Province

COVID-19 Uncertainty and Sleep: the Roles of Perceived Stress and Intolerance of Uncertainty During the Early Stage of the COVID-19 Outbreak

Investigation on sleep quality in Chinese medical staff during the COVID-19 pandemic

Sleep quality during and after severe acute respiratory syndrome coronavirus 2 (COVID‐19) lockdowns in the UK: Results from the SleepQuest study

Social Capital And Sleep Quality In Individuals Who Self-Isolated For 14 Days During The Coronavirus Disease 2019 (Covid-19) Outbreak In January 2020 In China

The Influencing Factors of Sleep Quality Among Chinese Junior and Senior High School Adolescents During the COVID-19 Pandemic